Cranberries and Digestive Health: Supporting the Stomach and Gut from Within

New Delhi [India], December 23: Across the globe, digestive disorders are rising, and nowhere is this more evident than in regions with high rates of Helicobacter pylori infection — a bacterium carried by nearly half the world’s population. In India and other Asian countries, H. pylori prevalence is especially high, raising the risk of chronic acidity, ulcers, and even stomach cancer. For decades, treatment has relied almost entirely on antibiotics, yet the need for gentler, complementary strategies has never been more urgent.

Cranberries, with their unique profile of polyphenols and proanthocyanidins (PACs), are emerging as a compelling ally in digestive health. A landmark double-blind, randomised, placebo-controlled trial involving 522 adults found that drinking cranberry juice containing 44 mg PACs twice a day for eight weeks resulted in a 20 percent reduction in H. pylori infection rates. What makes this meaningful is that cranberries don’t kill the bacteria; instead, they prevent H. pylori from attaching to the stomach lining. By interrupting this anchoring process, cranberries reduce the chance of inflammation and infection taking hold.

This anti-adhesion mechanism has broader implications. Because cranberries do not act like antibiotics, they pose no risk of contributing to antibiotic resistance — a critical advantage in India, where repeated antibiotic cycles are common. Cranberries offer a natural, well-tolerated complement to conventional therapy, and the study reported a compliance rate of 94 percent with no adverse effects.

Beyond the stomach, cranberries are also proving valuable for the gut microbiome. Their fibre and polyphenols act as prebiotics, supporting beneficial bacteria such as Bacteroidetes while reducing harmful strains linked to poor metabolic outcomes. Studies included in the Cranberry Institute guidebook note improvements in short-chain fatty acid production, gut barrier integrity, and overall microbial diversity — factors linked to reduced inflammation and improved immunity.

A healthy gut barrier is essential; when weakened, it can allow harmful molecules to pass into the bloodstream, triggering chronic inflammation that contributes to diabetes, heart disease, and autoimmune conditions. Cranberries, through their protective effects on both microbial balance and barrier function, help maintain the gut’s resilience.

Digestion, immunity, and long-term health are deeply connected, and cranberries sit at this intersection with a surprising amount of scientific backing. By integrating cranberry products into daily diets — from a morning glass of 100 percent cranberry juice to dried cranberries in meals — consumers can support their digestive systems in simple, enjoyable ways.

As more research emerges, one thing is clear. Cranberries don’t just brighten a plate; they fortify the invisible systems that keep digestion smooth, inflammation in check, and the stomach protected. In a landscape crowded with complex health challenges, they offer a small yet powerful step towards better gut health every day.

If you object to the content of this press release, please notify us at [email protected]. We will respond and rectify the situation within 24 hours.

Business

VAHH Chemicals Limited’s Initial Public Offering Opens on June 4 to June 8, 2026 with Price Fixed at Rs.60 Per Share

The Issue comprises a fresh issue of 22,42,000 equity shares aggregating to Rs.13.45 crore Surat (Gujarat) [India], June 03: VAHH Chemicals Limited (“Company”), a Gujarat based specialty chemicals company engaged in the manufacturing and trading of chemical products, has announced the opening of its Initial Public Offering (IPO). The Issue will open for subscription on […]

Read More
brand merchandising Business eyantra ventures Finance fy26 results healthcare Hyderabad IT Services nasa hospitals prismberry Revenue Growth

eYantra Ventures Limited Reports FY26 Annual Results

Consolidated Revenue of ₹94.7 Crores | Standalone Revenue ₹67.6 Crores | Brand Merchandising +183% YoY | IT Services +21% YoY | Portfolio Investment NASA Hospitals Grows 85% to ₹24.0 Crores Hyderabad (Telangana) [India], May 29: eYantra Ventures Limited (eYantra), a Hyderabad-based diversified enterprise services group, announced its audited annual results for the financial year ended […]

Read More
Business

VMS TMT Limited Announces Q4 FY26 and FY26 Results

Ahmedabad (Gujarat) [India], June 03: VMS TMT Limited (BSE: 544521 | NSE: VMSTMT), a fully integrated steel manufacturer engaged in TMT Bars and Billets, announced its Audited Financial Results for the Quarter and Year Ended March 31, 2026. The Company delivered a strong performance in Q4 FY26, supported by improved plant utilization, stable demand across […]

Read More